Basma Adeem Medical company (TADAWUL:9626)

TADAWUL:9626 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	20.05	8.12	5.16
Cash & Short-Term Investments	20.05	8.12	5.16
Cash Growth	146.91%	57.42%	-
Accounts Receivable	-	-	0.26
Other Receivables	0.6	0.51	0.18
Receivables	0.6	0.51	0.43
Inventory	1.15	0.6	0.12
Prepaid Expenses	0.37	0.36	0.09
Other Current Assets	0.02	0.05	0.06
Total Current Assets	22.19	9.64	5.86
Property, Plant & Equipment	15.63	7.29	7.23
Other Intangible Assets	0.07	0.04	0
Total Assets	37.89	16.96	13.09
Accounts Payable	1.08	1.17	1.6
Accrued Expenses	1.66	1.19	1.12
Current Portion of Leases	1.03	0.95	0.23
Current Income Taxes Payable	0.48	0.19	0.1
Other Current Liabilities	0.01	0.04	0.04
Total Current Liabilities	4.26	3.53	3.08
Long-Term Leases	10.77	3.43	4.89
Total Liabilities	15.58	7.16	8.15
Common Stock	16	0.1	0.05
Additional Paid-In Capital	1.6	1.14	1.19
Retained Earnings	6.31	8.56	3.7
Treasury Stock	-1.6	-	-
Shareholders' Equity	22.31	9.8	4.94
Total Liabilities & Equity	37.89	16.96	13.09
Total Debt	11.79	4.37	5.12
Net Cash (Debt)	8.25	3.75	0.04
Net Cash Growth	120.28%	9671.36%	-
Net Cash Per Share	0.71	0.39	-
Filing Date Shares Outstanding	14.4	18.4	-
Total Common Shares Outstanding	14.4	-	-
Working Capital	17.92	6.1	2.78
Book Value Per Share	1.55	-	-
Tangible Book Value	22.24	9.77	4.94
Tangible Book Value Per Share	1.54	-	-
Machinery	3.58	3.42	2.79
Leasehold Improvements	2	1.94	1.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.